WASHINGTON — The Food and Drug Administration said on Wednesday that it plans to take a far more aggressive stance in reporting on possible medical device hazards, in some cases issuing early warnings about safety risks even before those concerns have been validated.

The move follows several high-profile lawsuits involving safety risks and medical devices, as well as a string of warnings from the FDA about various products. Among them: a hip implant that was reported to leak metal parts into patients’ bloodstreams, an internal defibrillator that was reported to stop working, and a mesh implant used to prevent female incontinence that was reported to erode.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy